1-23431706-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000336689.8(ASAP3):c.2536G>A(p.Val846Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000158 in 1,523,480 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V846F) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000336689.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASAP3 | NM_017707.4 | c.2536G>A | p.Val846Ile | missense_variant | 23/25 | ENST00000336689.8 | NP_060177.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASAP3 | ENST00000336689.8 | c.2536G>A | p.Val846Ile | missense_variant | 23/25 | 1 | NM_017707.4 | ENSP00000338769.3 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152066Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000578 AC: 10AN: 172920Hom.: 0 AF XY: 0.0000766 AC XY: 7AN XY: 91352
GnomAD4 exome AF: 0.000168 AC: 231AN: 1371296Hom.: 0 Cov.: 32 AF XY: 0.000169 AC XY: 114AN XY: 674878
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152184Hom.: 0 Cov.: 30 AF XY: 0.0000672 AC XY: 5AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | The c.2536G>A (p.V846I) alteration is located in exon 23 (coding exon 23) of the ASAP3 gene. This alteration results from a G to A substitution at nucleotide position 2536, causing the valine (V) at amino acid position 846 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at